InvestorsObserver
×
News Home

Is Edgewise Therapeutics Inc (EWTX) a Good Buy in the Healthcare Sector?

Tuesday, February 27, 2024 11:30 AM | InvestorsObserver Analysts

Mentioned in this article

Is Edgewise Therapeutics Inc (EWTX) a Good Buy in the Healthcare Sector?

A rating of 97 puts Edgewise Therapeutics Inc (EWTX) near the top of the Healthcare sector according to InvestorsObserver. Edgewise Therapeutics Inc's score of 97 means that it ranks higher than 97% of stocks in the sector. In addition, its overall score of 92 ranks it higher than 92% of all stocks.

Overall Score - 92
EWTX has an Overall Score of 92. Find out what this means to you and get the rest of the rankings on EWTX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Edgewise Therapeutics Inc Stock Today?

Edgewise Therapeutics Inc (EWTX) stock is unchanged 0% while the S&P 500 has fallen -0.04% as of 11:27 AM on Tuesday, Feb 27. EWTX is unmoved $0.00 from the previous closing price of $17.04 on volume of 91,723 shares. Over the past year the S&P 500 is higher by 27.26% while EWTX has gained 80.51%. EWTX lost -$1.57 per share the over the last 12 months. Click Here to get the full Stock Report for Edgewise Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App